Skip to main content
. 2022 Aug 5;13:946351. doi: 10.3389/fphar.2022.946351

TABLE 2.

Severe potential drug-drug interactions that were found for at least 3 patients.

Drug-drug interaction Stockley’s Drugs.com MediQ Frequency, n (%)
Acetylsalicylic acid < = > Enoxaparin moderate severe moderate 21 (3.3%)
Enoxaparin < = > Ibuprofen moderate severe moderate 16 (2.6%)
Baclofen < = > Ibuprofen severe mild 15 (2.4%)
Ibuprofen < = > Methylprednisolone severe moderate 14 (2.2%)
Enoxaparin < = > Ramipril severe moderate mild 13 (2.1%)
Citalopram < = > Methylprednisolone severe moderate 10 (1.6%)
Dipyrone/metamizole < = > Methylprednisolone severe mild 9 (1.4%)
Methylprednisolone < = > Solifenacin severe 9 (1.4%)
Acetaminophen/paracetamol < = > Ibuprofen severe mild 7 (1.1%)
Citalopram < = > Fingolimod severe severe moderate 7 (1.1%)
Interferon beta-1a < = > Ramipril severe moderate 7 (1.1%)
Mitoxantrone < = > Ondansetron severe 7 (1.1%)
Acetylsalicylic acid < = > Ibuprofen severe severe moderate 6 (1.0%)
Amlodipine < = > Simvastatin mild severe moderate 6 (1.0%)
Citalopram < = > Ibuprofen severe moderate mild 6 (1.0%)
Ibuprofen < = > Teriflunomide severe 6 (1.0%)
Acetylsalicylic aci < = > Dipyrone/metamizole severe moderate 5 (0.8%)
Citalopram < = > Solifenacin severe severe moderate 5 (0.8%)
Methylprednisolone < = > Tizanidine severe 5 (0.8%)
Acetylsalicylic acid < = > Duloxetine severe moderate mild 4 (0.6%)
Candesartan < = > Enoxaparin severe moderate mild 4 (0.6%)
Citalopram < = > Fampridine severe 4 (0.6%)
Diclofenac < = > Enoxaparin moderate severe moderate 4 (0.6%)
Diclofenac < = > Methylprednisolone severe moderate 4 (0.6%)
Escitalopram < = > Pantoprazole severe mild 4 (0.6%)
Ramipril < = > Teriflunomide severe 4 (0.6%)
Ramipril < = > Tizanidine moderate severe mild 4 (0.6%)
Acetylsalicylic acid < = > Teriflunomide severe mild 3 (0.5%)
Acetylsalicylic acid < = > Venlafaxine severe moderate mild 3 (0.5%)
Amlodipine < = > Magnesium severe 3 (0.5%)
Baclofen < = > Levodopa severe moderate moderate 3 (0.5%)
Bisoprolol < = > Tamsulosin severe mild 3 (0.5%)
Ciprofloxacin< = > Methylprednisolone severe severe mild 3 (0.5%)
Citalopram < = > Dronabinol severe moderate mild 3 (0.5%)
Citalopram < = > Mitoxantrone severe 3 (0.5%)
Duloxetine < = > Ibuprofen severe moderate mild 3 (0.5%)
Enoxaparin < = > Valsartan severe moderate mild 3 (0.5%)
Escitalopram < = > Fingolimod severe severe moderate 3 (0.5%)
Escitalopram < = > Ibuprofen severe moderate mild 3 (0.5%)
Insulin glargine < = > Ramipril severe moderate mild 3 (0.5%)
Methylprednisolone < = > Teriflunomide severe 3 (0.5%)
Mitoxantrone < = > Solifenacin severe 3 (0.5%)
Solifenacin < = > Torasemide severe 3 (0.5%)

The medication schedules of a total of 627 patients with CIS/MS were evaluated using three drug interaction databases. This table lists 43 pDDIs (sorted by frequency) that were classified as severe in at least one of the databases and that were found for n ≥ 3 patients. Please note that the severity levels from Drugs.com (minor, moderate and major) and MediQ (low, average and high) were relabeled here according to those from Stockley’s. Disease-modifying drugs for MS are marked in bold. — = not recorded in the database; CIS, clinically isolated syndrome; MS, multiple sclerosis; pDDI, potential drug-drug interaction.